Sort   by:  
 Page size 
UnknownRUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
Not available
S-EPMC3295208 | biostudies-literature
UnknownComparative analysis of tandem repeats from hundreds of species reveals unique insights into centromere evolution.
Not available
S-EPMC4053949 | biostudies-literature
UnknownAntimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.
Not available
S-EPMC7334278 | biostudies-literature
UnknownDeterminants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.
Not available
S-EPMC5315445 | biostudies-literature
UnknownExpanding the diversity of mycobacteriophages: insights into genome architecture and evolution.
Not available
S-EPMC3029335 | biostudies-literature
UnknownIncidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Not available
S-EPMC6639714 | biostudies-literature
UnknownA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Not available
S-EPMC2806600 | biostudies-literature
UnknownA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Not available
S-EPMC2872173 | biostudies-literature
UnknownLiraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288 | biostudies-literature
UnknownExtracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors.
Not available
S-EPMC10962646 | biostudies-literature
Sort   by:  
 Page size